The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

The first human-tested weight-loss drug that burns calories through creatine-based heat generation, without reducing appetite, has successfully completed its Phase I trial.

MIT professor, Dr. Leonard Guarente, conducts research into sirtuin genes and the power of a molecule called NAD ...